Local media: UC, UC Health to examine potential COVID-19 treatment

In the absence of an approved treatment for COVID-19, in March the FDA began allowing researchers to request emergency authorization for the use of convalescent plasma which shows potential as a treatment for the disease.

Researchers at the UC College of Medicine are among those who joined the Mayo Clinic protocol for investigating convalescent plasma as a possible treatment for COVID-19. Convalescent plasma is obtained from people who have recovered from COVID-19 and have been free of symptoms for 28 days. This program may allow access to that plasma for hospitalized patients infected with the novel coronavirus who have severe or life-threatening COVID-19, or who may be at high risk for progression to severe or life-threatening disease.

This research garnered coverage from the Cincinnati Business Courier, Cincinnati Enquirer, WLWT, Fox19 and WVXU

Featured image at top from freestocks on Unsplash.

Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.

Related Stories

2

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.